Last reviewed · How we verify

NCT03819738

fMRI in Deep Brain Stimulation

Recruiting now NA Last updated 3 July 2024
What this trial tests

NA trial testing fMRI in Epilepsy in 20 participants. Currently enrolling.

Timeline
24 March 2017
Primary endpoint
10 January 2025
10 January 2025

Quick facts

Lead sponsorUniversitaire Ziekenhuizen KU Leuven
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment20
Start date24 March 2017
Primary completion10 January 2025
Estimated completion10 January 2025
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Universitaire Ziekenhuizen KU Leuven — full company profile →

Who can join

18 and older, any sex, with Epilepsy or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

With fMRI, we want to understand the mechanisms of brain neuromodulation in (dys)functional brain circuits, to obtain knowledge on involved brain networks in DBS.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Deep Brain Stimulation for the Management of Refractory Neurological Disorders: A Comprehensive Review.
    Rissardo JP, Vora NM, Tariq I, Mujtaba A, et al · · 2023 · cited 17× · PMID 38004040 · DOI 10.3390/medicina59111991

Verify or expand the search:

Other trials of fMRI

Trials testing the same drug.

Other recruiting trials for Epilepsy

Currently open trials in the same condition.

Other Universitaire Ziekenhuizen KU Leuven trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03819738.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing